ScholarIQanswers from OpenAlex & ORCID
Michelle M. Mielke
ResearcherPublications, citations & collaboration network
Michelle M. Mielke is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michelle M. Mielke have?
ScholarIQindexed works
Michelle M. Mielke has 980 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michelle M. Mielke have?
ScholarIQcitation count
Michelle M. Mielke has 47,449 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michelle M. Mielke?
ScholarIQh-index
Michelle M. Mielke has an h-index of 111 in OpenAlex.
What is the i10-index of Michelle M. Mielke?
ScholarIQi10-index
Michelle M. Mielke has an i10-index of 467 in OpenAlex.
What is the ORCID of Michelle M. Mielke?
ScholarIQorcid
The ORCID for Michelle M. Mielke is on the source record.
What is the OpenAlex record for Michelle M. Mielke?
ScholarIQopenalex
The OpenAlex for Michelle M. Mielke is on the source record.
What are the most-cited papers on Michelle M. Mielke?
ScholarIQmost cited works
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen, Rebecca E. Amariglio, Martin P.J. van Boxtel, Monique M.B. Breteler, Mathieu Ceccaldi, Gaël Chételat, Bruno Dubois, Carole Dufouil, Kathryn A. Ellis, Wiesje M. van der Flier, Lidia Glodzik, Argonde C. van Harten, Mony J. de Leon, Pauline McHugh, Michelle M. Mielke, José Luís Molinuevo, Lisa Mosconi, Ricardo S. Osorio, Audrey Perrotin, Ronald C. Petersen, Laura A. Rabin, Lorena Rami, Barry Reisberg, Dorene M. Rentz, Perminder S. Sachdev, Vincent de La Sayette, Andrew J. Saykin, Philip Scheltens, Melanie Shulman, Melissa J. Slavin, Reisa A. Sperling, Robert Stewart, Olga Uspenskaya, Bruno Vellas, Pieter Jelle Visser, Michael Wagner, Subjective Cognitive Decline Initiative (SCD‐I) Working Group
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Michelle M. Mielke, Prashanthi Vemuri, Walter A. Rocca
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi, Eider M. Arenaza‐Urquijo, Arlene Astell, Claudio Babiloni, Alex Bahar‐Fuchs, J. Simon Bell, Gene L. Bowman, Adam M. Brickman, Gaël Chételat, Carrie Ciro, Ann D. Cohen, Peggye Dilworth‐Anderson, Hiroko H. Dodge, Simone Dreux, Steven D. Edland, Anna J. Esbensen, Lisbeth Evered, Michael Ewers, Keith N. Fargo, Juan Fortea, Hector M. González, Deborah Gustafson, Elizabeth Head, James A. Hendrix, Scott M. Hofer, Leigh Johnson, Roos J. Jutten, Kerry Kilborn, Krista L. Lanctôt, Jennifer J. Manly, Ralph N. Martins, Michelle M. Mielke, Martha Clare Morris, Melissa E. Murray, Esther S. Oh, Mario A. Parra, Robert A. Rissman, Catherine M. Roe, Octavio A. Santos, Nikolaos Scarmeas, Lon S. Schneider, Nicole Schupf, Sietske A.M. Sikkes, Heather M. Snyder, Hamid R. Sohrabi, Yaakov Stern, André Strydom, Yi Tang, Graciela Muñiz‐Terrera, Charlotte E. Teunissen, Debora Melo van Lent, Michael Weinborn, Linda M.P. Wesselman, Donna M. Wilcock, Henrik Zetterberg, Sid E. O’Bryant
The Association of Neuropsychiatric Symptoms in MCI with Incident Dementia and Alzheimer Disease
Paul B. Rosenberg, Michelle M. Mielke, Brian S. Appleby, Esther S. Oh, Yonas E. Geda, Constantine G. Lyketsos
Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic
Sid E. O’Bryant, Michelle M. Mielke, Robert A. Rissman, Simone Lista, Hugo Vanderstichele, Henrik Zetterberg, Piotr Lewczuk, Holly Posner, James Hall, Leigh Johnson, Y L Fong, Johan Luthman, Andreas Jeromin, Richard Batrla‐Utermann, Alcibiades E. Villarreal, Gabrielle B. Britton, Peter J. Snyder, Kim Henriksen, Paula Grammas, Veer Bala Gupta, Ralph N. Martins, Harald Hampel, Biofluid Based Biomarker Professional Interest Area